G1 Therapeutics, Inc.
Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines

Last updated:

Abstract:

This invention is in the area of synthesizing pyrimidine-based compounds useful in the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.

Status:
Grant
Type:

Utility

Filling date:

21 Dec 2018

Issue date:

15 Dec 2020